Extramural Funding & Training Opportunities

NIH, NINR, and AHRQ Funding Opportunity Announcements

Dates and Deadlines	Title	Summary Information
Posted: October 4, 2019 Application Receipt Date(s): January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022	HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) RFA-NS-20-008	The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-008.html
Posted: October 3, 2019 Application Receipt Date(s): January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022	HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) RFA-NS-20-009	The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-009.html
Posted: October 4, 2019 Application Receipt Date(s): January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022	HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) RFA-NS-20-010	The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-010.html
Posted: October 1, 2019 Application Receipt Date(s): January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022	HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) RFA-NS-20-011	The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-011.html
Posted: April 16, 2019 Earliest submission date: September 4, 2019	Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) PAR-19-256	The purpose of this funding opportunity announcement (FOA) is to encourage modular budget R01 grant applications from nurse scientists who are currently or were supported within the last 3 years by an NIH Career Development (K) award. This opportunity is limited to those K awardee nurse scientists who have NIH New Investigator status. Through this opportunity, NINR seeks to enhance the transition of nurse scientists to independent investigator status. https://grants.nih.gov/grants/guide/pa-files/PAR-19-256.html
Posted: August 2, 2018	Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis Related Announcements and FOAs: NOT-HS-19-011 PA-18-793 PA-18-794 PA-18-795 PA-16-223 PA-17-232	The purpose of this Notice is to inform the research community that the Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to advance our nation's understanding of the opioids crisis and provide solutions for addressing it. This effort is part of AHRQ’s commitment to supporting the HHS 5-point strategy to address the opioids crisis: Better addiction prevention, treatment, and recovery services, Better data, Better targeting of overdose-reversing drugs, Better pain management, and Better research. AHRQ already is contributing to the HHS strategy by funding research to increase the use of medication-assisted treatment (MAT) in primary care practice; supporting the development of systematic evidence reviews; making available implementation tools, and producing actionable data utilizing the Medical Expenditure Panel Survey and Healthcare Cost and Utilization Project. In this SEN, AHRQ is interested in health services research to improve pain management, opioid abuse prevention, opioid abuse treatment and recovery, and overdose prevention and treatment with a high degree of interest applications that respond to the following three specific areas of focus: Evaluating state, local, and health system policy efforts to address the opioids crisis: Many state and local governments and large health systems are enacting policies to address the opioid crisis, including improving pain management. There is enormous potential to learn from these local experiences and provide evidence-based guidance to policy makers about the effects, including understanding the unintended consequences, of new policies. AHRQ is interested in supporting rapid-cycle, high-quality evaluations of policy interventions and strongly encourages collaboration with policy implementers (including government agencies and health systems) within proposals. Developing and evaluating interventions to prevent progression to opioid use disorders in people who are misusing or have experimented with opioids: While there are evidence-based interventions, including medication-assisted treatment, for people with opioids use disorder, far less is known about how health care delivery systems can assist people who have used opioids non-medically but are not addicted. Understanding and addressing the rapid increase in opioid-related hospitalizations among older adults. AHRQ data have demonstrated that prescription opioids use has increased among adults 65 years of age and older with a corresponding increase in the rates of opioid-related emergency room visits and hospitalizations. The reasons for the high use of opioids and the adverse effects among the elderly are not widely understood and interventions to address the opioid crisis targeting the needs of younger adults and heroin users may not be applicable to this population. AHRQ has a particular interest in health service research applications that address the experience, needs, preferences, and outcomes of priority populations including children and adolescents, women, older adults, people with chronic medical conditions, racial and ethnic minorities, low-income, and rural populations. The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). AHRQ also is interested in receiving career development awards (PA-16-223 and PA-17-232) that propose developing generalizable health service research skills through projects related to the opioids crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the opioid crisis (PA-18-765). Applicants should clearly state in their cover letter and project summary of their grant application that they are responding to this SEN by including the title and number of this SEN (NOT-HS-18-015). Applications responding to this SEN should be submitted on regular application receipt dates identified in the respective Funding Opportunity Announcement and will be reviewed by AHRQ standing study sections. Applicants should consider this SEN active until September 30, 2021. Inquiries Please direct all inquiries to: Lisa Scott-Morring, MS, MSHS, CRA Director, Division for Policy, Coordination and Analysis Agency for Healthcare Research and Quality, HHS Office of Extramural Research, Education, and Priority Populations Email: Lisa.Scott-Morring@ahrq.hhs.gov
Posted: July 21, 2019 Earliest submission date: September 5, 2019	Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) PAR-19-321	The purpose of this funding opportunity is to stimulate research aimed at determining needs and best practices for the integration of palliative care into home and community settings. Home and community in this FOA refer to the place where an individual resides or lives. Home- and community-based palliative care programs ensure those with serious, advanced illness who do not require hospitalization but are not appropriate for hospice have access to high quality end-of-life and palliative care. https://grants.nih.gov/grants/guide/pa-files/PAR-19-321.html
Posted: July 21, 2019 Earliest submission date: September 16, 2019	Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) PAR-19-320	The purpose of this funding opportunity is to stimulate research aimed at determining needs and best practices for the integration of palliative care into home and community settings. Home and community in this FOA refer to the place where an individual resides or lives. Home- and community-based palliative care programs ensure those with serious, advanced illness who do not require hospitalization but are not appropriate for hospice have access to high quality end-of-life and palliative care. https://grants.nih.gov/grants/guide/pa-files/PAR-19-320.html
Posted Date: August 2, 2018 This Special Emphasis Notice will expire on September 30, 2021.	Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis NOT-HS-18-015	The Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to advance our nation's understanding of the opioids crisis and provide solutions for addressing it. The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). AHRQ also is interested in receiving career development awards (PA-16-223 and PA-17-232) that propose developing generalizable health service research skills through projects related to the opioids crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the opioid crisis (PA-18-765). https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-015.html
Posted Date: March 27, 2019	Notice of Availability of Administrative Supplements for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Administrative Supplement/ Clinical Trial Optional) NOT-OD-19-087	The National Institutes of Health Office of the Director announces the opportunity for investigators with relevant active NIH-supported research project grants from the participating Institutes listed above to submit administrative supplement applications for funded projects to meet new NIH Down syndrome research objectives related to the NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project (https://www.nih.gov/include-project). This notice is soliciting administrative supplements for the following mechanisms ONLY: Resource-Related Research Projects (R24), Research Program Projects and Centers (P01, P30, P50) cooperative agreements (U10, U19, U24, U54, UG1, UG3, UL1 ) Resource-Related Research Multi-Component Projects and Centers Cooperative Agreements (U2C), and training programs (T32). https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-087.html
Posted Date: March 12, 2019 Application Due Date: May 13, 2019 by 5pm local time of applicant organization This RFA will expire on May 14, 2019.	Administrative Supplement for Research on Bioethical Issues PA-19-217	Consideration of ethical issues associated with biomedical research is intrinsic to the responsible conduct of science and the translation of scientific and technological advances into practice. The investment in and the integration of bioethics-related research and policy demonstrates NIH’s commitment to safeguarding the integrity of the research that it conducts and supports. Interested applicants may supplement parent awards focused on bioethics or add a component related to bioethics to a parent award in which bioethics was not the focus. Issues addressed are expected to fall within the scope of research and policy activities of the NIH but may be beyond the focus of any one Institute or Center. In addition to overarching areas of interest, individual Institutes and Centers have indicated specific areas of research interest within the announcement. Complete Information, including how to apply can be found here.
Posted December 21, 2018 Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-19-134	The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution. https://grants.nih.gov/grants/guide/pa-files/PAR-19-134.html
Posted December 21, 2018 Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-19-135	The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and health professional institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution. https://grants.nih.gov/grants/guide/pa-files/PAR-19-135.html
Posted Date: Dec 21, 2018 Standard dates apply by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022	End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses R21 Clinical Trial Optional: PAR-19-153 R01 Clinical Trial Optional: PAR-19-136	The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 – 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers. To access the application and additional information, please visit: R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-136.html
Posted Date: Nov 7, 2018 Standard dates apply, by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022.	Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals R21 Clinical Trial Optional: PAR-19-058 R01 Clinical Trial Optional: PAR-19-057	The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities. To access the application and additional information, please visit: R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-058.html R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-057.html
Posted Date: Nov 7, 2018 Standard dates apply, by 5:00 PM local time of applicant organization. Letter of Intent due 30 days prior to the application due date This FOA will expire on Jan 8, 2022.	NINR Clinical Trial Planning Grant R34 Clinical Trial Required: PAR-19-060	The purpose of this Funding Opportunity Announcement (FOA) is to provide time and support for the applicant to develop and finalize plans for the design and execution of investigator-initiated clinical trials that are highly relevant to the NINR mission. Activities supported by this planning grant must include feasibility and pilot studies that inform the intervention viability and/or the trial design. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-060.html
Posted Date: Oct 31, 2018 Standard dates apply, by 5:00 PM local time of applicant organization This FOA will expire on Jan 8, 2022.	End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms R21 Clinical Trial Optional: PAR-19-044 R01 Clinical Trial Optional: PAR-19-045	The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html
Posted Date: Jan 24, 2018 Application Due Dates: March 27, 2018; February 20, 2019; and February 20, 2020, by 5:00 PM local time of applicant organization Letter of Intent due 30 days prior to the application due date This FOA will expire on February 21, 2020.	Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings R61/R33 Clinical Trial Required: PAR-18-585	This FOA invites applications for pragmatic trials for dementia care in Long-term Services and Support (LTSS) settings which will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings. These trials are intended to produce results that can be directly adopted by healthcare providers, patients or caregivers for rapid translation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care in LTSS; and/or (4) reduce disparities in LTSS care. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-585.html
Posted Date: Dec 15, 2017 Standard dates apply, by 5PM local time This FOA will expire on May 8, 2021.	End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness R21 Clinical Trial Optional: PA-18-499 R01 Clinical Trial Optional: PA-18-498	This funding opportunity announcement (FOA) seeks to stimulate research focused on identification of the key barriers to effective end-of-life and palliative care (EOLPC) health literacy in diverse settings and populations, and to create novel strategies, interventions, and models of care to improve EOLPC health literacy, with the goal of improving outcomes for individuals with serious, advanced illness and their families and caregivers. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-498.html R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-499.html
Posted Date: Jan 8, 2019 Standard dates apply by 5:00 PM local time of applicant organization Letter of Intent Due 30 days prior to the application due date This FOA will expire on Jan 8, 2021	NHLBI Clinical Trial Pilot Studies R34 Clinical Trial Optional: PAR-19-155	This Funding Opportunity Announcement (FOA) is to support studies that are scientifically essential, yet also sufficient, for investigators to make definitive decisions that inform the final designs of important Phase II and beyond clinical trials within NHLBI's mission; that is, clinical trials with the primary intent of testing the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed studies are both necessary and sufficient to permit definitive decisions about the final design of the subsequent clinical trial. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-155.html
Posted Date Nov 30, 2017 Application Due Dates: June 11, 2018; October 8, 2018; June 10, 2019, by 5PM local time of applicant organization This FOA will expire June 11, 2019.	Building Evidence: Effective Palliative/End of Life Care Interventions R01 Clinical Trial Optional: PAR-18-173	This funding opportunity announcement (FOA) seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-173.html
Posted Date: Nov 28, 2017 Application Due Dates: April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization Letter of Intent Due Date: 30 days before application due date This FOA will expire April 12, 2019	Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization R21 Clinical Trial Optional: PAR-18-247 R01 Clinical Trial Optional: PAR-18-246	This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-247.html R01: https://grants.nih.gov/grants/guide/pa-files/PAR-18-246.html
Posted Date: Nov 8, 2017 Standard dates apply, by 5:00 PM local time of applicant organization. This FOA will expire on May 8, 2020	Promoting Caregiver Health Using Self-Management R01 Clinical Trial Optional: PA-18-150	The purpose of this initiative is to stimulate research in promoting caregiver health using self-management. Caregiving is an important science area since the number of people living longer with chronic conditions is growing. Informal caregivers (lay caregivers) are defined as unpaid individuals (spouses, partners, family members, friends, or neighbors) involved in assisting others with activities of daily living and/or medical tasks. Formal caregivers are paid, delivering care in one’s home or care settings (daycare, residential care facility). This concept focuses on informal caregivers. To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PA-18-150.html
Posted Date: Nov 7, 2017 Standard dates apply, by 5:00 PM local time This FOA will expire on Jan 8, 2020.	Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice R21 Clinical Trial Optional: PA-18-166 R01 Clinical Trial Optional: PA-18-148	This funding opportunity announcement (FOA) seeks to stimulate research that focuses on reducing negative individual and family outcomes related to unwanted transitions at the end of life and optimizing the individual and family outcomes related to high quality coordination of care of care of individuals who are enrolled in hospice. This FOA emphasizes individuals who are receiving hospice care and their family caregivers, in any setting where hospice care is provided, including their home, a relative’s home, a hospice inpatient facility, an assisted living facility, a short- or long-term care facility, or a hospital. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-166.html R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-148.html
Posted Date: Nov 7, 2017 Standard dates apply, by 5:00 PM local time of applicant organization. This FOA will expire on Jan 8, 2020	Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers R21 Clinical Trial Optional: PA-18-167 R01 Clinical Trial Optional: PA-18-149	This funding opportunity announcement (FOA) seeks to expand knowledge and increase the evidence base for palliative care (PC) in advanced rare diseases, including rare cancers, and to improve physical and psychosocial well-being and quality of life among seriously ill individuals and their family caregivers. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-167.html R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-149.html
Posted Date: Nov 3, 2017 (R21, R01); May 10, 2016 (R03) Standard dates apply by 5:00 PM local time of applicant organization Letter of Intent Due 30 days prior to the application due date This FOA will expire on May 8, 2019	Dissemination and Implementation Research in Health R21 Clinical Trial Optional: PAR-18-017 R01 Clinical Trial Optional: PAR-18-007 R03 Small Grant Program: PAR-16-237	This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services into public health, clinical practice, and community settings. To access the application and additional information, please visit: R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-017.html R01:https://grants.nih.gov/grants/guide/pa-files/PAR-18-007.html R03: https://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html

Dates and Deadlines

Title

Summary Information

Posted: October 4, 2019

Application Receipt Date(s):
January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

RFA-NS-20-008

The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-008.html

Posted: October 3, 2019

Application Receipt Date(s):
January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

RFA-NS-20-009

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-009.html

Posted: October 4, 2019

Application Receipt Date(s):
January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

RFA-NS-20-010

The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-010.html

Posted: October 1, 2019

Application Receipt Date(s):
January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

RFA-NS-20-011

The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies.

https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-011.html

Posted: April 16, 2019

Earliest submission date: September 4, 2019

Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional)

PAR-19-256

The purpose of this funding opportunity announcement (FOA) is to encourage modular budget R01 grant applications from nurse scientists who are currently or were supported within the last 3 years by an NIH Career Development (K) award. This opportunity is limited to those K awardee nurse scientists who have NIH New Investigator status. Through this opportunity, NINR seeks to enhance the transition of nurse scientists to independent investigator status.

https://grants.nih.gov/grants/guide/pa-files/PAR-19-256.html

Posted: August 2, 2018

Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis

Related Announcements and FOAs:

NOT-HS-19-011
PA-18-793
PA-18-794
PA-18-795
PA-16-223
PA-17-232

The purpose of this Notice is to inform the research community that the Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to advance our nation's understanding of the opioids crisis and provide solutions for addressing it.

This effort is part of AHRQ’s commitment to supporting the HHS 5-point strategy to address the opioids crisis: Better addiction prevention, treatment, and recovery services, Better data, Better targeting of overdose-reversing drugs, Better pain management, and Better research. AHRQ already is contributing to the HHS strategy by funding research to increase the use of medication-assisted treatment (MAT) in primary care practice; supporting the development of systematic evidence reviews; making available implementation tools, and producing actionable data utilizing the Medical Expenditure Panel Survey and Healthcare Cost and Utilization Project.

In this SEN, AHRQ is interested in health services research to improve pain management, opioid abuse prevention, opioid abuse treatment and recovery, and overdose prevention and treatment with a high degree of interest applications that respond to the following three specific areas of focus:

Evaluating state, local, and health system policy efforts to address the opioids crisis: Many state and local governments and large health systems are enacting policies to address the opioid crisis, including improving pain management. There is enormous potential to learn from these local experiences and provide evidence-based guidance to policy makers about the effects, including understanding the unintended consequences, of new policies. AHRQ is interested in supporting rapid-cycle, high-quality evaluations of policy interventions and strongly encourages collaboration with policy implementers (including government agencies and health systems) within proposals.
Developing and evaluating interventions to prevent progression to opioid use disorders in people who are misusing or have experimented with opioids: While there are evidence-based interventions, including medication-assisted treatment, for people with opioids use disorder, far less is known about how health care delivery systems can assist people who have used opioids non-medically but are not addicted.
Understanding and addressing the rapid increase in opioid-related hospitalizations among older adults. AHRQ data have demonstrated that prescription opioids use has increased among adults 65 years of age and older with a corresponding increase in the rates of opioid-related emergency room visits and hospitalizations. The reasons for the high use of opioids and the adverse effects among the elderly are not widely understood and interventions to address the opioid crisis targeting the needs of younger adults and heroin users may not be applicable to this population.

AHRQ has a particular interest in health service research applications that address the experience, needs, preferences, and outcomes of priority populations including children and adolescents, women, older adults, people with chronic medical conditions, racial and ethnic minorities, low-income, and rural populations.

The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). AHRQ also is interested in receiving career development awards (PA-16-223 and PA-17-232) that propose developing generalizable health service research skills through projects related to the opioids crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the opioid crisis (PA-18-765).

Applicants should clearly state in their cover letter and project summary of their grant application that they are responding to this SEN by including the title and number of this SEN (NOT-HS-18-015). Applications responding to this SEN should be submitted on regular application receipt dates identified in the respective Funding Opportunity Announcement and will be reviewed by AHRQ standing study sections. Applicants should consider this SEN active until September 30, 2021.

Inquiries

Please direct all inquiries to:

Lisa Scott-Morring, MS, MSHS, CRA
Director, Division for Policy, Coordination and Analysis
Agency for Healthcare Research and Quality, HHS
Office of Extramural Research, Education, and Priority Populations
Email: Lisa.Scott-Morring@ahrq.hhs.gov

Posted: July 21, 2019

Earliest submission date: September 5, 2019

Palliative Care in Home and Community Settings (R01 Clinical Trial Optional)

PAR-19-321

The purpose of this funding opportunity is to stimulate research aimed at determining needs and best practices for the integration of palliative care into home and community settings. Home and community in this FOA refer to the place where an individual resides or lives. Home- and community-based palliative care programs ensure those with serious, advanced illness who do not require hospitalization but are not appropriate for hospice have access to high quality end-of-life and palliative care.

https://grants.nih.gov/grants/guide/pa-files/PAR-19-321.html

Posted: July 21, 2019

Earliest submission date: September 16, 2019

Palliative Care in Home and Community Settings (R21 Clinical Trial Optional)

PAR-19-320

https://grants.nih.gov/grants/guide/pa-files/PAR-19-320.html

Posted Date: August 2, 2018

This Special Emphasis Notice will expire on September 30, 2021.

Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis

NOT-HS-18-015

The Agency for Healthcare Research and Quality (AHRQ) is interested in receiving health services research grant applications to advance our nation's understanding of the opioids crisis and provide solutions for addressing it.

https://grants.nih.gov/grants/guide/notice-files/NOT-HS-18-015.html

Posted Date: March 27, 2019

Notice of Availability of Administrative Supplements for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Administrative Supplement/ Clinical Trial Optional)

NOT-OD-19-087

The National Institutes of Health Office of the Director announces the opportunity for investigators with relevant active NIH-supported research project grants from the participating Institutes listed above to submit administrative supplement applications for funded projects to meet new NIH Down syndrome research objectives related to the NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project (https://www.nih.gov/include-project). This notice is soliciting administrative supplements for the following mechanisms ONLY: Resource-Related Research Projects (R24), Research Program Projects and Centers (P01, P30, P50) cooperative agreements (U10, U19, U24, U54, UG1, UG3, UL1 ) Resource-Related Research Multi-Component Projects and Centers Cooperative Agreements (U2C), and training programs (T32).

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-087.html

Posted Date: March 12, 2019

Application Due Date: May 13, 2019 by 5pm local time of applicant organization

This RFA will expire on May 14, 2019.

Administrative Supplement for Research on Bioethical Issues

PA-19-217

Consideration of ethical issues associated with biomedical research is intrinsic to the responsible conduct of science and the translation of scientific and technological advances into practice. The investment in and the integration of bioethics-related research and policy demonstrates NIH’s commitment to safeguarding the integrity of the research that it conducts and supports.

Interested applicants may supplement parent awards focused on bioethics or add a component related to bioethics to a parent award in which bioethics was not the focus. Issues addressed are expected to fall within the scope of research and policy activities of the NIH but may be beyond the focus of any one Institute or Center. In addition to overarching areas of interest, individual Institutes and Centers have indicated specific areas of research interest within the announcement. Complete Information, including how to apply can be found here.

Posted December 21, 2018

Standard dates apply, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

PAR-19-134

The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution.

https://grants.nih.gov/grants/guide/pa-files/PAR-19-134.html

Posted December 21, 2018

Standard dates apply, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

PAR-19-135

The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to stimulate basic and clinical research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. REAP grants create opportunities for scientists and health professional institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. REAP grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students at health professional schools or graduate schools to meritorious research projects, and to strengthen the research environment of the applicant institution.

https://grants.nih.gov/grants/guide/pa-files/PAR-19-135.html

Posted Date: Dec 21, 2018

Standard dates apply by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses

R21 Clinical Trial Optional: PAR-19-153

R01 Clinical Trial Optional: PAR-19-136

The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 – 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers.

To access the application and additional information, please visit:

R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-136.html

Posted Date: Nov 7, 2018

Standard dates apply, by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022.

Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals

R21 Clinical Trial Optional: PAR-19-058

R01 Clinical Trial Optional: PAR-19-057

The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities.

To access the application and additional information, please visit:

R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-058.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-057.html

Posted Date: Nov 7, 2018

Standard dates apply, by 5:00 PM local time of applicant organization.

Letter of Intent due 30 days prior to the application due date

This FOA will expire on Jan 8, 2022.

NINR Clinical Trial Planning Grant

R34 Clinical Trial Required: PAR-19-060

The purpose of this Funding Opportunity Announcement (FOA) is to provide time and support for the applicant to develop and finalize plans for the design and execution of investigator-initiated clinical trials that are highly relevant to the NINR mission. Activities supported by this planning grant must include feasibility and pilot studies that inform the intervention viability and/or the trial design.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-060.html

Posted Date: Oct 31, 2018

Standard dates apply, by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022.

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms

R21 Clinical Trial Optional: PAR-19-044

R01 Clinical Trial Optional: PAR-19-045

The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html

R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html

Posted Date: Jan 24, 2018

Application Due Dates: March 27, 2018; February 20, 2019; and February 20, 2020, by 5:00 PM local time of applicant organization

Letter of Intent due 30 days prior to the application due date

This FOA will expire on February 21, 2020.

Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings

R61/R33 Clinical Trial Required: PAR-18-585

This FOA invites applications for pragmatic trials for dementia care in Long-term Services and Support (LTSS) settings which will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings. These trials are intended to produce results that can be directly adopted by healthcare providers, patients or caregivers for rapid translation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care in LTSS; and/or (4) reduce disparities in LTSS care.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-585.html

Posted Date: Dec 15, 2017

Standard dates apply, by 5PM local time

This FOA will expire on May 8, 2021.

End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness

R21 Clinical Trial Optional: PA-18-499

R01 Clinical Trial Optional: PA-18-498

This funding opportunity announcement (FOA) seeks to stimulate research focused on identification of the key barriers to effective end-of-life and palliative care (EOLPC) health literacy in diverse settings and populations, and to create novel strategies, interventions, and models of care to improve EOLPC health literacy, with the goal of improving outcomes for individuals with serious, advanced illness and their families and caregivers.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-498.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-499.html

Posted Date: Jan 8, 2019

Standard dates apply by 5:00 PM local time of applicant organization

Letter of Intent Due 30 days prior to the application due date

This FOA will expire on Jan 8, 2021

NHLBI Clinical Trial Pilot Studies

R34 Clinical Trial Optional: PAR-19-155

This Funding Opportunity Announcement (FOA) is to support studies that are scientifically essential, yet also sufficient, for investigators to make definitive decisions that inform the final designs of important Phase II and beyond clinical trials within NHLBI's mission; that is, clinical trials with the primary intent of testing the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed studies are both necessary and sufficient to permit definitive decisions about the final design of the subsequent clinical trial.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-155.html

Posted Date Nov 30, 2017

Application Due Dates: June 11, 2018; October 8, 2018; June 10, 2019, by 5PM local time of applicant organization

This FOA will expire June 11, 2019.

Building Evidence: Effective Palliative/End of Life Care Interventions

R01 Clinical Trial Optional: PAR-18-173

This funding opportunity announcement (FOA) seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-173.html

Posted Date: Nov 28, 2017

Application Due Dates: April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization

Letter of Intent Due Date: 30 days before application due date

This FOA will expire April 12, 2019

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization

R21 Clinical Trial Optional: PAR-18-247

R01 Clinical Trial Optional: PAR-18-246

This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-247.html

R01: https://grants.nih.gov/grants/guide/pa-files/PAR-18-246.html

Posted Date: Nov 8, 2017

Standard dates apply, by 5:00 PM local time of applicant organization.

This FOA will expire on May 8, 2020

Promoting Caregiver Health Using Self-Management

R01 Clinical Trial Optional: PA-18-150

The purpose of this initiative is to stimulate research in promoting caregiver health using self-management. Caregiving is an important science area since the number of people living longer with chronic conditions is growing. Informal caregivers (lay caregivers) are defined as unpaid individuals (spouses, partners, family members, friends, or neighbors) involved in assisting others with activities of daily living and/or medical tasks. Formal caregivers are paid, delivering care in one’s home or care settings (daycare, residential care facility). This concept focuses on informal caregivers.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PA-18-150.html

Posted Date: Nov 7, 2017

Standard dates apply, by 5:00 PM local time

This FOA will expire on Jan 8, 2020.

Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice

R21 Clinical Trial Optional: PA-18-166

R01 Clinical Trial Optional: PA-18-148

This funding opportunity announcement (FOA) seeks to stimulate research that focuses on reducing negative individual and family outcomes related to unwanted transitions at the end of life and optimizing the individual and family outcomes related to high quality coordination of care of care of individuals who are enrolled in hospice. This FOA emphasizes individuals who are receiving hospice care and their family caregivers, in any setting where hospice care is provided, including their home, a relative’s home, a hospice inpatient facility, an assisted living facility, a short- or long-term care facility, or a hospital.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-166.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-148.html

Posted Date: Nov 7, 2017

Standard dates apply, by 5:00 PM local time of applicant organization.

This FOA will expire on Jan 8, 2020

Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers

R21 Clinical Trial Optional: PA-18-167

R01 Clinical Trial Optional: PA-18-149

This funding opportunity announcement (FOA) seeks to expand knowledge and increase the evidence base for palliative care (PC) in advanced rare diseases, including rare cancers, and to improve physical and psychosocial well-being and quality of life among seriously ill individuals and their family caregivers.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-167.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-149.html

Posted Date: Nov 3, 2017 (R21, R01); May 10, 2016 (R03)

Standard dates apply by 5:00 PM local time of applicant organization

Letter of Intent Due 30 days prior to the application due date

This FOA will expire on May 8, 2019

Dissemination and Implementation Research in Health

R21 Clinical Trial Optional: PAR-18-017

R01 Clinical Trial Optional: PAR-18-007

R03 Small Grant Program: PAR-16-237

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services into public health, clinical practice, and community settings.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-017.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-18-007.html

R03: https://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html

Other Funding and Training Opportunities

Dates and Deadlines	Title	Summary Information
Rolling deadline Currently accepting applications to begin positions Spring/Summer 2020	Palliative Care and Aging Research Training (T32) Opportunity	Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI). More information about T32 opportunities at Colorado University Palliative Care Post-Doctoral Research Fellowship Programs Flyer
Application Due Date: February 1^st of desired start year Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled.	Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32)	This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults. Please see the links below for more information: Behavioral Geriatrics T32 Flyer T32 Program Information Translational Research Institute for Pain in Later Life (TRIPLL) Weill Cornell Medical Center for Research on End-of-Life Care
Applications are accepted on a rolling basis for a variety of potential start dates	Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program	Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease. For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com or email us at pallcntr@uw.edu

Dates and Deadlines

Title

Summary Information

Rolling deadline

Currently accepting applications to begin positions Spring/Summer 2020

Palliative Care and Aging Research Training (T32) Opportunity

Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI).

More information about T32 opportunities at Colorado University

Palliative Care Post-Doctoral
Research Fellowship Programs Flyer

Application Due Date: February 1^st of desired start year

Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled.

Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32)

This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults.

Please see the links below for more information:

Applications are accepted on a rolling basis for a variety of potential start dates

Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program

Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease.

For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com
or email us at pallcntr@uw.edu

Other Resources:

National Institute of Nursing Research (NINR)

National Institutes of Health (NIH)

Agency for Healthcare Research and Quality (AHRQ)

Opioid-specific AHRQ resources

Extramural Funding & Training Opportunities

NIH, NINR, and AHRQ Funding Opportunity Announcements

Other Funding and Training Opportunities

Other Resources:

Announcements

Tweets from @PCRCGroup

NIH Extramural Nexus